MAPT and Alzheimer disease: While positive amyloid PET indicates AD status in general, fluorodeoxyglucose PET (FDG-PET), and tau ligand binding suggest five subtypes: typical amnestic syndrome, logopenic variant of primary progressive aphasia, posterior cortical atrophy, corticobasal syndrome, and frontal AD (Dubois et al., 2023).